Amy S. Gardiner
- Molecular Biology
- Genetics top 2%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Immunology top 10%
- Co-authors
- David OscierRobert P. EdwardsIván MartínezFederico A. MonzonS A KhanTerry J. HamblinZadie DavisFreda K. Stevenson
- Topics
- Chronic Lymphocytic Leukemia Research (12 papers)RNA Research and Splicing (8 papers)Cancer-related molecular mechanisms research (7 papers)
- Journals
- Nucleic Acids ResearchBloodPLoS ONE
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Amy S. Gardiner
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 604
- Genetics 554
- Cancer Research 449
- Pathology and Forensic Medicine 410
- Immunology 288
Countries citing papers authored by Amy S. Gardiner
This map shows the geographic impact of Amy S. Gardiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Gardiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Gardiner more than expected).
Fields of papers citing papers by Amy S. Gardiner
This network shows the impact of papers produced by Amy S. Gardiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Gardiner. The network helps show where Amy S. Gardiner may publish in the future.
Co-authorship network of co-authors of Amy S. Gardiner
This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Gardiner. A scholar is included among the top collaborators of Amy S. Gardiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Gardiner. Amy S. Gardiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 22 | |
| 5 | 20 | |
| 6 | 0 | |
| 7 | 47 | |
| 8 | 22 | |
| 9 | 25 | |
| 10 | 1 | |
| 11 | 46 | |
| 12 | 35 | |
| 13 | 75 | |
| 14 | 293 | |
| 15 | 5 | |
| 16 | 63 | |
| 17 | Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocyte leukemia | 12 |
| 18 | 34 | |
| 19 | 36 | |
| 20 | 92 |
About Amy S. Gardiner
Amy S. Gardiner is a scholar working on Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), RNA Research and Splicing (8 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Genetics (554 citations), Cancer Research (449 citations) and Pathology and Forensic Medicine (410 citations). Amy S. Gardiner has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David Oscier, Robert P. Edwards, Iván Martínez, Federico A. Monzon, S A Khan, Terry J. Hamblin, Zadie Davis, Freda K. Stevenson, Nora I. Perrone‐Bizzozero and Jennifer Orchard. Their work appears in journals such as Nucleic Acids Research, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.